GOP Senator Wants Time Frame And Other Details On FDA’s AI/ML Action Plan

Sen. Bill Cassidy lauded the US Food and Drug Administration for its recently released artificial intelligence and machine learning software action plan, but seems to be pressing the agency step up the pace with a list of pointed questions.

The FDA’s Center for Devices and Radiological Health (CDRH) published last month a five-point action plan on how it wants to regulate AI/ML software as a medical device (SaMD). Part...